Moreover, high expression of both ACE2 and BRD4 mRNAs compared with low ACE2 plus low BRD4 levels also predicted significantly reduced survival in colorectal cancer patients (p = 0.0174, Fig. 1e). This evidence concerns the gene BRD4 and colorectal cancer.